10times
Ended

Utilizing the Measurement of Cognition to Determine Drug Safety in Late Phase Clinical Trials

Virtual Conference

defaultAdd a Review

SelectSelectSaveShare
AboutSpeakersFollowersExhibitorsReviews

Average post reach is 125.3k users. Start networking today!

profile_pic

Post

Evaluation of CNS drug impact on cognition, memory, and attention is crucial in drug development, not only for psychiatric or neurological drugs but also for others with potential CNS effects. Early-phase studies determine adverse effects as any cognition decline due to drug or dose.

Listed In

Average post reach is 125.3k users. Start networking today!

profile_pic

Post

Timings


Entry Fees

Check Official Website

Estimated Turnout

upto 100
Delegates
Based on previous editions

Event Type

Conference

Editions

Nov 2024


Frequency Not Available

Official Links

WebsiteContacts



Report Error
Claim this event

Organizer

Logo

Queries about the event? Ask Organizer
Xtalks Canada1437 Total Events

-75.250973-0.071389

Venue Map & Directions

Booking.com
Venue to be announced

Online

Write a Review

Add Your Review
EditionNov 2024

How did you participate in this event?

Visitor
Exhibitor
Speaker

Invite users with similar interest

View More

Sponsors

Selected